Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huazhuo Xingxue Granules is a Traditional Chinese Medicine (TCM) herbal formulation developed for the treatment of metabolic disorders, specifically non-alcoholic fatty liver disease (NAFLD). The formula is designed based on the TCM principles of "resolving turbidity" (huazhuo) and "promoting blood circulation" (xingxue) to address the underlying pathology of qi stagnation and blood stasis. Clinical research, particularly at the Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, focuses on its ability to improve liver function, reduce lipid accumulation, and modulate metabolic markers in patients with NAFLD. It is often evaluated in clinical trials as an adjunct to other interventions such as acupuncture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huazhuo xingxue granules.